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FOXP3 was discovered through the genetic 
analysis of patients with the hereditary mono-
genic disorder immune dysregulation, poly-
endocrinopathy, enteropathy, X-linked syndrome. 
Concurrently, disruption of the murine homo-
logue Foxp3 was found to be the causal muta-
tion underlying the scurfy phenotype. The lesions 
observed in mouse and man included lym-
phoadenopathy and splenomegaly, exfoliative 
dermatitis and eczema, autoimmune thrombo-
cytopenia, type 1 diabetes, and autoimmune 
thyroiditis (1–4). Despite the identifi  cation of 
the genetic basis of the disorder in humans and 
mice, its immunological mechanism has long 
been the subject of a great deal of controversy. 
Although several studies suggested that the 
autoimmune lesions in mice are mediated by 
T cells (5–9), early BM transplantation experi-
ments showed that the transfer of mutant he-
matopoietic stem cells into lethally irradiated 
wild-type recipients by itself does not result in 
pathology (2). In agreement with these results, 
transplantation of mutant Foxp3sf thymi into 
nude or SCID recipients resulted in the charac-
teristic disease (10). Collectively, these studies 
implicated impaired diff  erentiation of T cells 
in Foxp3-defi  cient thymic stroma as a cause of 
pathology. The evidence in favor of the latter 
possibility remained inconclusive, however, be-
cause the aforementioned inability of Foxp3 
mutant BM-derived cells to induce disease in 
Foxp3sf ® Foxp3wt recipients can be explained 
by surviving radio-resistant wild-type host T 
cells capable of providing protection. Indeed, 
the presence of as little as 3–5% of wild-type 
BM is suffi   cient to rescue the disease in mixed 
BM chimeras (11). Furthermore, the transfer 
of disease via thymic transplant into a lym-
phopenic host can be explained by the pres-
ence of pathogenic thymocytes within the 
transplanted thymus.
More recent studies have provided a radi-
cally diff  erent explanation for of the pathol-
ogy associated with Foxp3 defi  ciency. Foxp3 
was suggested to be a “master regulator” of 
CD4+CD25+ T regulatory (T reg) cell diff  er-
entiation because these cells fail to diff  erentiate 
in the absence of Foxp3, and forced expression 
of Foxp3 facilitates diff  erentiation of periph-
eral non–T reg cells into T reg cells  (12–14). 
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Foxp3 is essential for the commitment of differentiating thymocytes to the regulatory 
CD4+ T (T reg) cell lineage. In humans and mice with a genetic Foxp3 defi  ciency, absence 
of this critical T reg cell population was suggested to be responsible for the severe auto-
immune lesions. Recently, it has been proposed that in addition to T reg cells, Foxp3 is also 
expressed in thymic epithelial cells where it is involved in regulation of early thymocyte 
differentiation and is required to prevent autoimmunity. Here, we used genetic tools to 
demonstrate that the thymic epithelium does not express Foxp3. Furthermore, we formally 
showed that genetic abatement of Foxp3 in the hematopoietic compartment, i.e. in T cells, 
is both necessary and suffi  cient to induce the autoimmune lesions associated with Foxp3 
loss. In contrast, deletion of a conditional Foxp3 allele in thymic epithelial cells did not 
result in detectable changes in thymocyte differentiation or pathology. Therefore, in mice 
the only known role for Foxp3 remains promotion of T reg cell differentiation within the 
T cell lineage, whereas there is no role for Foxp3 in thymic epithelial cells.
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Because transfection of Foxp3 endows the transfected cells 
expressing high levels of Foxp3 with suppressive properties 
(13, 14), and in mixed BM chimeras generated upon trans-
ferring of Foxp3− and Foxp3+ BM into Rag2−/− recipients 
T reg cells diff  erentiate only from the Foxp3+ BM, a T cell–
intrinsic role for Foxp3-mediated regulation of tolerance was 
proposed. This view was formally established by the observa-
tion of indistinguishable disease in mice with the germline- 
and CD4-Cre–mediated T cell lineage–restricted ablation of 
a conditional Foxp3Flox allele (15).
However, a recent study by Chang et al. (16, 17) revived 
the old argument by raising an interesting possibility that 
Foxp3 is expressed in the thymus not only in diff  erentiating 
T reg cells but also in the thymic epithelium. It was further 
proposed that Foxp3 expressed in the thymic epithelium 
plays an essential role in the regulation of double negative 
(DN) thymocyte maturation and that its dysregulation in the 
absence of Foxp3 results in fatal autoimmunity. In agreement 
with this idea, Foxp3wt Rag−/− recipients reconstituted with 
Foxp3− BM did not manifest fatal autoimmunity (16).
To resolve this continuing controversy, we have used a ge-
netic approach to revisit potential Foxp3 expression and its role 
in the thymic epithelium. We found no evidence for Foxp3 
expression or function in the thymic epithelium in suppressing 
the autoimmune symptoms associated with Foxp3 defi  ciency 
and in guiding early thymocyte diff  erentiation.  Our  results 
demonstrate that Foxp3 has a solely T cell–intrinsic function 
required to maintain tolerance and prevent autoimmunity.
RESULTS AND DISCUSSION
No detectable Foxp3 protein expression 
in the thymic epithelium
Recently, apparent expression of Foxp3 in the majority of 
thymic epithelial cells was observed in experiments using 
fl  ow cytometry while a subset of thymic cortical epithelial 
cells was found positive for Foxp3 by immunofl  uorescence 
(16). Because epithelial cells are notorious for a high degree 
of nonspecifi  c antibody binding in fl  ow cytometric assays and 
are tightly associated with thymocytes in situ, potentially 
leading to false positive results in immunofl  uorescence assays, 
we sought to reexamine Foxp3 expression in thymic epithe-
lial cells and thymocytes by fl  ow cytometric analysis of ge-
netically marked Foxp3-expressing cells using knock-in mice 
harboring a Foxp3gfp reporter allele.
Previously, through examination of thymic tissue sections 
using immunofl  uorescence, we found Foxp3GFP protein pre-
dominantly expressed in the medullary region in the thymus 
with rare Foxp3+ cells in the cortex (15). The cortical ex-
pression of GFP was previously ascribed to expression by the 
few CD4+CD8+ double positive (DP) thymocytes that are 
GFP+ by fl  ow cytometry (15). To determine if this expression 
was due instead to epithelial cell expression of the Foxp3GFP 
allele, we performed fl  ow cytometric analysis of purifi  ed 
CD45− thymic stroma from Foxp3GFP mice and found no 
expression of GFP (Fig. 1 A). For in situ analysis of epithelial 
cells, we crossed the Foxp3GFP allele into the Rag2−/− mouse 
line. Consistent with our previous studies, no expression of 
Foxp3 was observed in thymocytes isolated from Rag2−/− 
Foxp3GFP mice (not depicted). This fi  nding allowed us to 
examine Foxp3 expression in thymic stromal cells using 
  immunofl  uorescence in the absence of “contaminating” Foxp3-
expressing thymocytes by examining GFP expression using 
anti-GFP antibody (not depicted) and polyclonal affi   nity-
  purifi  ed rabbit antibody specifi  c for Foxp3 (Fig. 1 B). We 
found no sign of Foxp3 expression in Rag-defi  cient stroma 
above background fl  uorescence observed for Foxp3− mice, 
whereas Foxp3 expression was readily detectable in control 
Rag-suffi   cient mice (Fig. 1 B). These data demonstrate that 
the thymic epithelium did not express detectable levels of 
Foxp3 protein within the sensitivity limit of these assays.
Disruption of Foxp3 in thymocytes is necessary 
and suffi  cient to cause autoimmune syndromes
Although the aforementioned studies failed to detect Foxp3 
protein in thymic epithelial cells, it can be argued that our 
detection of Foxp3 protein is not suffi   ciently sensitive. Thus, 
the possibility remained that low level of Foxp3 expression in 
thymic epithelial cells at a certain stage of T cell diff  erentia-
tion is required for prevention of autoimmunity. We ad-
dressed this possibility by ablation of a conditional Foxp3Flox 
allele using Cre recombinase expressed exclusively in thymic 
epithelial cells. Because the Foxn1 gene is the highly specialized 
Figure 1.  No expression of Foxp3 in the thymic epithelium. 
(A) Expression of GFP in CD45− thymic stroma from wild-type (shaded) 
and Foxp3GFP mice (line). Data is representative of four independent 
  experiments. (B) Immunohistochemical analysis of Foxp3 expression in the 
thymus of Foxp3GFP, Foxp3GFPRag2−/−, and Foxp3−Rag−/− mice. Thymic 
sections were stained with the affi  nity-purifi  ed rabbit anti-Foxp3 anti-
body. Bar, 100 μm.JEM VOL. 204, March 19, 2007  477
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regulator of thymic epithelial cell diff  erentiation and is not 
expressed in BM-derived cells, we bred Foxp3Flox mice with 
mice harboring Cre recombinase knocked into the 3′ un-
translated region of the Foxn1 locus (Foxn1Cre; unpublished 
data). The resulting Foxp3Flox × Foxn1Cre mice were exam-
ined for signs of lymphoproliferative autoimmune disease and 
compared with Foxp3Flox × CD4-Cre mice.
The interpretation of these experiments, however, was 
critically dependent on the specifi   city of CD4-Cre– and 
Foxn1Cre-mediated deletion. In this regard, it was proposed 
that the autoimmunity previously reported in Foxp3Flox × 
CD4-Cre mice (15) is due to CD4-Cre–mediated deletion of 
the Foxp3 allele in a subset of CD4-expressing thymic epithe-
lial cells. To directly address this issue, we fi  rst examined 
CD4 expression on CD45− thymic stromal cells using fl  ow 
cytometry and failed to fi  nd CD4+ thymic epithelial cells 
(Fig. 2 A). Next, we tested the cell type specifi  city of recom-
bination mediated by CD4-Cre and Foxn1Cre using the 
Rosa26-stopFlox-YFP recombination reporter allele as a ge-
netic fate-mapping tool. We found that CD4-Cre induced 
recombination in the majority of thymocytes, but no recom-
bination was detectable in the CD45− thymic stroma (Fig. 
2 A). On the contrary, Foxn1Cre-induced recombination oc-
curred in the majority of CD45−G8.8+ thymic epithelial 
cells, but not CD45−G8.8− stromal cells or thymocytes (Fig. 
2 B). A comparable extent of Foxp3 deletion in purifi  ed 
CD45−G8.8+ thymic epithelial cells from Foxp3Flox × Foxn1Cre 
was confi  rmed by genomic PCR (not depicted). When 
the CD45−G8.8+ population was subdivided according to 
the expression of UEA-1 or MHC class II, both subsets 
showed similar levels of Cre-mediated recombination (not 
depicted). Foxn1Cre was therefore active in the vast majority 
of thymic epithelial cells, but not fi  broblasts or thymocytes. 
Importantly, Foxp3Flox × Foxn1Cre mice remained as healthy 
as Foxp3WT × Foxn1Cre littermates and showed no signs of 
T cell activation (not depicted), tissue pathology, or wasting 
disease (Fig. 2 C). In contrast, Foxp3Flox × CD4-Cre mice 
developed lethal autoimmune lesions indistinguishable from 
those in Foxp3− mice in full agreement with our previously 
reported observations (15). Thus, Foxp3 gene ablation in 
thymic epithelium does not result in autoimmunity.
These results were further supported by our experiments 
using transfers of T cell–depleted Foxp3− and Foxp3wt BM, 
either separately or mixed at a 1:1 ratio into sublethally irra-
diated Rag2−/− recipients. All recipients of Foxp3− BM died 
by 6–7 wk of age from severe autoimmune disease, whereas 
recipients of Foxp3wt BM and mixed BM chimeras remained 
healthy (not depicted). Although donor BM was depleted of 
CD4+ and CD8+ T cells using magnetic bead sorting, it is 
impossible to formally exclude the possibility of a few patho-
genic T cells remaining in the preparations of Foxp3− BM. In 
addition, our experiments also diff  ered from those previously 
reported by Chang et al. in using mice harboring a Foxp3− 
allele generated through targeted mutagenesis and spontane-
ous Foxp3sf mutation, respectively. To defi  nitively exclude 
these possible explanations for the contradictory results from 
Figure 2.  Disruption of Foxp3 in the T cell lineage is necessary and 
suffi  cient to cause autoimmune syndrome. (A) No expression of CD4 
in the CD45− thymic stroma. Left: expression of CD4 in wild-type CD45− 
thymic stroma. Thymic stromal cells were analyzed after incubation with 
anti-CD4 antibodies (solid line) or no antibody control (shaded). Right: 
expression of YFP in CD45− thymic stroma and CD45+ thymocytes from 
wild-type (shaded) and Rosa-stopfl  YFP × CD4-Cre (solid line) mice. Data 
representative of 11 and 3 experiments, respectively. (B) Expression of YFP 
from wild-type (shaded) and Rosa-stopfl  YFP × Foxn1Cre (line) mice in 
CD45−G8.8+ epithelium, CD45−G8.8− stroma, and thymocytes. Data is 
representative of three experiments. (C) Analysis of gross clinical signs 
and lung and skin histopathology in Foxp3fl   × Foxn1Cre (n = 7; no histo-
logical infi  ltrates at 4 or 9 wk of age, no visible disease at >16 wk of age), 
Foxp3fl   × CD4-Cre (n = 6; average life span 4 wk), Foxp3− (n = 7; aver-
age life span 4 wk), and wild-type or Foxp3fl   mice (n = 9; no histological 
infi  ltrates or visible disease at >16 wk of age). Bar, 1 cm. For representa-
tive histology sections shown, lung and ear skin were taken from 4-wk-old 
male Foxp3fl  , Foxp3fl   CD4-Cre, and Foxp3fl   Foxn1Cre mice. Arrows indicate 
infl  ammatory infi  ltrate. Bar, 100 μm. (D) Disease onset in neonatal Rag1−/− 
mice reconstituted with Foxp3 scurfy nude BM (■; n = 4) or Foxp3 wild-
type nude BM (▲; n = 4), and neonatal Rag1−/− Foxp3 scurfy mice 
 reconstituted  with  Foxp3 scurfy nude BM (□; n = 5) or Foxp3 wild-type 
nude BM (●; n = 6). 478  RESTRICTION OF FOXP3 TO T CELLS | Liston et al. 
the two sets of BM transfer studies, we crossed the Foxp3sf 
  allele to the Foxn1-defi  cient nude mice, which are character-
ized by an early block in thymic epithelium diff  erentiation 
and thus lack mature T cells. As previously reported, Foxp3sf 
nude mice were not aff  ected by the autoimmunity (2). Thus, 
we were able to transfer BM isolated from these disease-free 
mice into Rag1−/− recipients without the risk of contamina-
tion with mature pathogenic T cells. In these experiments, 
Foxp3sf nude BM reconstitution of neonatal Rag1−/− mice 
and Foxp3sfRag1−/− mice (serving as a positive control) re-
sulted in identical lethal lymphoproliferative disease (Fig. 
2 D). In contrast, control Foxp3wt nude BM transfers into either 
neonatal Rag1−/− or Foxp3sfRag1−/− did not result in disease 
(Fig. 2 D). The fi  ndings above demonstrate that genetic abla-
tion of Foxp3 in the thymic epithelium is neither necessary 
nor suffi   cient for the development of autoimmune disease.
Distorted thymopoiesis associated with Foxp3 defi  ciency is 
secondary to lymphoproliferative autoimmune syndrome
Lack of autoimmunity in Foxp3wt nude ® Foxp3sf Rag1−/− BM 
chimeras and in Foxp3fl o x Foxn1Cre mice did not exclude the 
previously proposed role for expression of Foxp3 in the thymic 
epithelium in normal thymopoiesis (16). Major thymic aberra-
tions reported for Foxp3 mutant mice include a decrease in 
thymic cellularity and in the proportion of CD4+CD8+ DP 
thymocytes (16). To reexamine this possibility, we analyzed 
thymopoiesis in Foxp3−,  Foxp3fl o x CD4-Cre, and Foxp3fl o x 
Foxn1Cre mice and found that both Foxp3− and the Foxp3fl  
CD4-Cre mice showed reduced total thymic cellularity and a 
decrease in the percentage of CD4+CD8+ DP thymocytes, 
whereas Foxp3fl o x Foxn1Cre mice were identical to their wild-
type littermates (Fig. 3, A and B). These results demonstrate 
that deletion of the Foxp3 gene in thymic epithelial cells does 
not result in detectable changes in thymic T cell maturation, 
and that an apparent decrease in DP thymocyte subset size and 
in total thymocyte numbers is due to loss of Foxp3 in thymo-
cytes rather than in the thymic epithelium and is most likely 
secondary to the severe autoimmunity and cytokine storm 
common to the Foxp3sf, Foxp3−, and Foxp3fl  CD4-Cre mice.
In addition to the aforementioned changes in thymocyte 
subsets, an expansion of DN1 (CD44+CD25−) cells was re-
ported for both Foxp3sf and Foxp3sf Rag−/− mice (16). To ex-
amine this phenomenon, we fi  rst analyzed the composition 
of DN thymocyte subsets in Foxp3−, Foxp3fl  CD4-Cre, and 
Foxp3fl  Foxn1Cre mice. The relative size of the DN1-4 thy-
mocyte subsets was not altered in Foxp3fl  Foxn1Cre as com-
pared with control mice; however, we found relative increases 
in the DN1 subset in Foxp3− and Foxp3fl  CD4-Cre mice 
(Fig. 3, C and D). To determine whether this is a cell-intrin-
sic defect in developing thymocytes, we analyzed DN thy-
mocyte subsets in disease-free Foxp3−Rag2−/− and control 
Foxp3wtRag2−/− littermates. No diff   erences in the relative 
sizes of DN1, DN2, and DN3 subsets were detected in these 
mice (Fig. 4, A and B). To exclude the possibility that very 
few thymic epithelial cells escaping Cre-mediated deletion in 
Foxp3fl o x × Foxn1Cre mice are capable of supporting normal 
thymocyte development, we generated an additional set 
of BM chimeras by transferring wild-type BM into 
Foxp3−Rag2−/− and Foxp3wtRag2−/− recipients. The matura-
tion of wild-type thymocytes was not diff  erent in the two sets 
Figure 3.  Distorted thymopoiesis is dependent on Foxp3 loss in the 
T cell lineage. Thymopoiesis was assessed by examining total thymus 
cellularity and by fl  ow cytometric analysis of thymocyte subsets. (A) Rep-
resentative CD4 and CD8 thymocyte profi  les for wild-type, Foxp3-defi  -
cient, Foxp3fl   CD4-Cre, and Foxp3fl   Foxn1Cre mice. Average thymus 
cellularity (mean ± SD) is shown below each graph. (B) Percentages of 
thymocytes in CD4−CD8− DN, CD4+CD8+ DP, CD4+ single positive, and 
CD8+ single positive subsets. Each data point represents a single mouse. 
(C) Representative fl  ow cytometric profi  les of DN thymocyte subsets and 
(D) percentages of DN1, DN2, DN3, and DN4 subsets in wild-type, Foxp3-
defi  cient, Foxp3fl   CD4-Cre, and Foxp3fl   Foxn1Cre mice. JEM VOL. 204, March 19, 2007  479
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of chimeric mice (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20062465/DC1). Together with the 
absence of expression of Foxp3 in DN thymocytes, these ex-
periments show that the changes in DN thymocyte matura-
tion observed in Foxp3 mutant mice are secondary eff  ects of 
massive peripheral T cell activation.
Collectively, our data demonstrates that the thymic epi-
thelium does not express detectable amounts of Foxp3 pro-
tein, and that there are no measurable adverse eff  ects  on 
immunological tolerance attributable to Foxp3 defi  ciency in 
thymic stromal cells or in other radiation-resistant nonhema-
topoietic cells. This conclusion is strongly supported by the 
lack of autoimmune manifestations and changes in thymo-
cyte maturation upon Foxn1-Cre–mediated ablation of a 
conditional Foxp3 allele in the thymic epithelium. In con-
trast, in control experiments, Foxp3 ablation in the T cell lin-
eage resulted in lethal autoimmune pathology typical of 
germline  Foxp3 mutation, as previously reported. In full 
agreement with these data are the results of the BM transfer 
experiments, which showed that Foxp3 defi  ciency in hema-
topoietic cells is solely responsible for autoimmunity, and 
that perturbed thymocyte subsets in Foxp3-defi  cient mice are 
an indirect consequence of pathology. Thus, in mice the only 
known role for Foxp3 remains promotion of T reg cell dif-
ferentiation within the T cell lineage.
MATERIALS AND METHODS
Mice. Foxp3− (14), Foxp3fl   (14), Foxp3GFP (15), CD4-Cre (18), Foxn1ex9cre 
(unpublished data; Cre was inserted along with an internal ribosome entry 
site into the 3′ untranslated region of the Foxn1 gene), ROSA-stopfl  -YFP 
(19), Foxp3sf, nude, Rag1−/−, and Rag2−/− mice have all been backcrossed 
to the B6 background. B6 Foxp3sf mice were backcrossed either to the B6 
nude or B6 Rag1−/− backgrounds two generations to produce Foxp3sf nude 
and Foxp3sf Rag1−/− strains. BM chimeras were constructed using 7 × 106 
BM cells/recipient harvested from athymic nude male mice with or without 
the Foxp3sf mutation and injected i.p. into neonatal (2–3 d) Rag1−/− with 
or without the Foxp3sf. Experimental mice were age and sex matched 
and  housed in specifi   c pathogen-free conditions. Disease incidence was 
monitored by frequent visual observation, and postmortem histological 
analysis of the tissues was performed using hematoxylin and eosin staining 
(Histology Consultation Services). All mice were used in accordance with 
guidelines from the Institutional Animal Care Committee of the University 
of Washington.
Flow cytometry and immunofl  uorescence. 5–10-wk-old mice were ana-
lyzed using the following antibodies: CD45-APC, I-Ab–PE, CD4-PE-Cy7, 
CD44-PE, CD8-PerCP, CD25-APC, CD8-FITC, CD4-PerCP, and UEA-1 
biotin, followed by SAV-PerCP (all from BD Biosciences) and G8.8 superna-
tant conjugated to Alexa 647. Thymic stroma preparations were enriched from 
three to six pooled thymi from 5–10-wk-old mice as described previously (20). 
After enzymatic enrichment, CD45− thymic stromal cells were purifi  ed using 
CD45 microbeads (Miltenyi Biotec) and the AutoMACS system (Miltenyi 
Biotec) as per the manufacturer’s recommendations before fl  ow cytometric 
analysis (21). Thymic sections were prepared and stained as described previ-
ously (22) using rabbit polyclonal IgG anti-Foxp3 antibodies (14), followed by 
Alexa 546–conjugated goat anti–rabbit IgG. Images were acquired using a 
Leica SP1/MP confocal microscope.
Online supplemental material. Fig. S1 shows early thymopoiesis for 
wild-type BM-derived thymocytes developing in Foxp3-suffi   cient  and 
Foxp3-defi  cient hosts assessed by CD44/CD25 fl  ow cytometric profi  les of 
CD4−CD8− thymocytes 4 wk after BM transfer. Fig. S1 is available at 
http://www.jem.org/cgi/content/full/jem.20062465/DC1.
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Figure 4.  Foxp3 defi  ciency does not affect early thymopoiesis in 
disease-free Rag-defi  cient mice. (A) Representative fl  ow cytometric 
analysis of DN1, DN2, DN3, and DN4 thymocyte subsets and (B) their 
percentages in Rag2−/− and Foxp3-defi  cient Rag2−/− mice. Each point 
represents a single mouse (n = 5). No statistically signifi  cant differences 
were observed between two groups of mice. 480  RESTRICTION OF FOXP3 TO T CELLS | Liston et al. 
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